Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice.
The transaction values Alimera at approximately $381m in upfront consideration. Credit: Red Vector via Shutterstock. ANI Pharmaceuticals is broadening its reach into the rare disease
WASHINGTON — As weight loss medications have exploded in popularity, a bill to allow Medicare to cover the drugs has languished virtually unchanged in Congress